GRCE
NASDAQ · Pharmaceuticals
Grace Therapeutics Inc
$1.87
+0.09 (+5.06%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,134.8% upside
Low Target
$18.68
Average Target
$23.09
High Target
$33.94
Current Price
$1.87
Current
$1.87
$1.87
Target
$23.09
$23.09
$18.68
$23.09 avg
$33.94
Scenario Analysis
Bear Case
$18.68
898.9%
Low target
Base Case
$23.09
+1,134.8%
Avg target
Bull Case
$33.94
+1,715.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$5.18
-63.9% from high
52-Week Low
$1.67
+12.0% from low
Target vs 52W High
$23.09
+345.8% vs high
Next Earnings Report
Nov 16, 2026
8d
until earnings
EPS Est: $-0.15
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals